Innaxon Therapeutics seeks to grow through collaborations, partnerships and new ventures.

Where appropriate, we pursue key technology and product licensing/acquisition strategies to build our future value. By implementing this strategy, we will continue in its quest to become a leading provider of smart (bio-)pharmaceutical products, which modulate the master key of the innate immune system -Toll-like Receptor 4- to serve serious, unmet medical needs.

Product/technology development opportunities that are of interest to Innaxon fall into the following commercial areas:

  • Therapeutic Vaccines and Adjuvants
  • Infectious Diseases
  • Immunotherapy of Cancer
  • Anti-inflammatories

If you have any questions about Innaxon Business Development activities, please contact:

Innaxon Therapeutics
Business Development and Alliances
Unit DX
St. Philips Central
Albert Road
Bristol
BS2 0XJ
United Kingdom

Phone:  +44 (0)1684 851 274
Email: info@innaxon.com